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Abstract
To slow the inexorable rise of antibiotic resistance we must understand how drugs impact on pathogenesis and influence
the selection of resistant clones. Staphylococcus aureus is an important human pathogen with populations of antibiotic-
resistant bacteria in hospitals and the community. Host phagocytes play a crucial role in controlling S. aureus infection,
which can lead to a population ‘‘bottleneck’’ whereby clonal expansion of a small fraction of the initial inoculum founds a
systemic infection. Such population dynamics may have important consequences on the effect of antibiotic intervention.
Low doses of antibiotics have been shown to affect in vitro growth and the generation of resistant mutants over the long
term, however whether this has any in vivo relevance is unknown. In this work, the population dynamics of S. aureus
pathogenesis were studied in vivo using antibiotic-resistant strains constructed in an isogenic background, coupled with
systemic models of infection in both the mouse and zebrafish embryo. Murine experiments revealed unexpected and
complex bacterial population kinetics arising from clonal expansion during infection in particular organs. We subsequently
elucidated the effect of antibiotic intervention within the host using mixed inocula of resistant and sensitive bacteria. Sub-
curative tetracycline doses support the preferential expansion of resistant microorganisms, importantly unrelated to effects
on growth rate or de novo resistance acquisition. This novel phenomenon is generic, occurring with methicillin-resistant S.
aureus (MRSA) in the presence of b-lactams and with the unrelated human pathogen Pseudomonas aeruginosa. The
selection of resistant clones at low antibiotic levels can result in a rapid increase in their prevalence under conditions that
would previously not be thought to favor them. Our results have key implications for the design of effective treatment
regimes to limit the spread of antimicrobial resistance, where inappropriate usage leading to resistance may reduce the
efficacy of life-saving drugs.
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Introduction
Staphylococcus aureus is an opportunistic human pathogen that
causes skin and tissue abscesses, occasionally leading to severe
systemic illness and death [1]. Whilst the process of lesion
formation itself is becoming better defined [2], the dynamics of a
bacterial population within the host during infection are far less
well understood. Whilst it is likely that infection progression and
tissue tropism vary between different strains of S. aureus (such as
those that cause osteomyelitis or keratitis [3,4]), research on
zebrafish embryos and mice has indicated an important role of
host phagocytes in the infection process [5–8]. This leads to an
infection ‘‘bottleneck’’ in which a small fraction of the initial
inoculum goes on to found a systemic infection. Previous studies
have identified bottleneck phenomena for a range of bacterial
species [9,10].
S. aureus is infamous for its rapid development of antibiotic
resistance, which has grown increasingly more relevant with the
widespread use of antimicrobials in agriculture and medicine.
Alarmingly, where once it was restricted to health-care settings,
drug-resistant S. aureus is now also found in the wider community
[11,12]. Bacteria resistant to antibiotics such as methicillin and
tetracycline have been shown to colonize humans in contact with
antibiotic-treated livestock [13,14]. The emergence of antibiotic
resistance in staphylococcal species has been the subject of much
study; classically, studies and analyses have focused on the
generation of resistance, persistence or tolerance due to advanta-
geous mutations in a sensitive bacterial population challenged by
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high levels of antibiotics [15–17]. Development of resistance may
come at a fitness cost [18], although S. aureus may be able to
circumvent this cost via methods such as phenotypic switching
[19]. Likewise, resistance to some drugs (including tetracycline and
oxacillin) is known to be inducible [20,21].
Of current interest is the effect of sub-curative concentrations of
antibiotics; that is, treatment that confers no significant improve-
ment in the wellbeing of the host. Such low levels of antibiotics
might be generated during failure to complete a treatment regime,
or encountered via the hospital environment or in agriculture. The
effects of a reduced antibiotic dose are the focus of several recent
studies and reviews, again largely concerning the generation of
mutants [22–24]. This area of research spans agriculture
[13,14,25,26], medicine [27,28] and food safety [29] and examines
multiple bacterial genera. For example, Pseudomonas aeruginosa has
been shown to acquire antibiotic resistance more rapidly in the
presence of low levels of antibiotic [30], and is known to be
associated with staphylococcal infection, particularly in the lungs
of cystic fibrosis patients [31]. Selection of antibiotic-resistant
clones during low-level treatment in vivo, however, has not been
directly examined.
In this study we use a set of isogenic, antibiotic-resistant strains
to investigate the bacterial population dynamics within both
zebrafish embryo and murine systemic infection models. Using
these strains, we elucidate the effect of low levels of antibiotics on
bacteria in vivo, showing that it is possible to confer an advantage to
an antibiotic-resistant strain, even at levels of antibiotics that do
not affect the growth rate of an antibiotic-sensitive strain or its
ability to cause a lethal infection.
Results
Construction and characterization of antibiotic-resistant
Staphylococcus aureus strains
In order to enhance the ability of infection dynamics studies to
examine disease progression in both zebrafish embryos and mice,
a set of three antibiotic-resistant S. aureus strains were constructed
in the SH1000 background: erythromycin/lincomycin-resistant,
EryR (GMSA015); kanamycin-resistant, KanR (GMSA016); and
tetracycline-resistant, TetR (GMSA017). Growth of the three
strains in vitro under favorable conditions exactly matched the wild
type parent SH1000 (Figure S1A). Furthermore, virulence assays
in the zebrafish embryo model (1500 CFU administered into the
circulation at 30 hours post fertilization) resulted in the pattern of
mortality one would expect from wild type bacteria (Figure S1B).
Resistance cassettes were then transduced into a second strain
background, NewHG, creating strains GMSA021, GMSA022 and
GMSA023 (EryR, KanR and TetR respectively). NewHG is a
Newman derivative in which the gene encoding regulator SaeS
has been repaired, resulting in a level of expression of saeS and
downstream virulence factors that matches many other S. aureus
strains, including the community-acquired methicillin-resistant S.
aureus (MRSA) lineage USA300, as opposed to the much higher
levels of expression seen in the presence of the Newman allele [32].
Three-strain infection dynamics in the zebrafish embryo
model
Previous work in the zebrafish embryo model suggested that
growth of bacteria in vivo, leading to lethality, occurs after a
biological ‘‘bottleneck’’ that often results in clonal expansion of a
single strain [5]. This phenomenon was demonstrated by infecting
zebrafish embryos 30 hours post fertilization with 1500 CFU of a
1:1:1 mixture of the three SH1000 strains (GMSA015-017) and
enumerating the strains present in each embryo post mortem
(Figure 1A). Infection with NewHG strains (GMSA021-023) gave
similar results (Figure 1B). In both backgrounds, differential clonal
expansion produced cases wherein either one or two strains out of
three predominated (alongside cases wherein all three strains grew
equally). There was no preference for the growth of any particular
strain over its competitors, with all three antibiotic resistance
cassettes proving equally capable of being selected (p.0.1), in
agreement with previously published results [5]. Furthermore, we
isolated clones that had been selected in vivo and, after mixing with
‘‘naı¨ve’’ bacteria, reintroduced them into the zebrafish model. We
found that there was no increase in the selection of these clones
relative to their naı¨ve counterparts over three successive passages,
suggesting a lack of adaptive mutations, as expected [5]. Therefore
in vivo clonal population expansion of the three strains is likely to be
entirely stochastic and, hence, endpoint enumeration of these
Author Summary
Staphylococcus aureus is a major cause of human disease,
made even more notable due to the spread of antibiotic
resistance. We used a combination of animal models to
study the spread of bacteria between organs during an
infection and the resulting effect of antibiotic intervention.
We found that S. aureus infection is highly clonal, following
a ‘‘bottleneck’’ in which very few bacterial cells found each
abscess. Despite previous in vitro research, the effect of
antibiotics on S. aureus infection was poorly understood.
We utilized our systemic infection models to study
intervention with sub-curative antibiotic doses, such as
one might encounter upon failing to complete an
antibiotic course. We have shown that such doses are
able to support the preferential expansion of antibiotic-
resistant organisms during a mixed infection. This selection
is due to the clonal pattern of infection, occurring despite
a lack of effect on growth rate or on the spontaneous
generation of resistance. Furthermore, it is generic to
multiple pathogen species, including Pseudomonas aeru-
ginosa, and antibiotic classes, such as with methicillin-
resistant S. aureus (MRSA) in the presence of oxacillin.
Given the current debate in the field, our results have
important implications for the design of properly-con-
trolled treatment regimes.
Figure 1. The stochastic distribution of bacterial strains post
mortem in zebrafish embryos. Embryos were infected with a 1:1:1
mixture of three antibiotic resistance-marked, but otherwise isogenic,
strains. Each pie chart represents a single embryo infected with
S. aureus (A) SH1000 variants or (B) NewHG variants. Total bacterial load
in each case was approximately 106 CFU.
doi:10.1371/journal.ppat.1003959.g001
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strains is a suitable and reliable method to investigate in vivo
dynamics.
A mixed, three-strain infection reveals complex pathogen
dynamics within the murine host
It is known that intravenous S. aureus infection results in kidney
abscesses [2,33] and that these likely originate from a small
number of founding bacteria [5]. Modeling of infection dynamics
has been performed in the murine model using other organisms,
including Salmonella enterica [9], Bacillus anthracis [10] and Yersinia
pseudotuberculosis [34]. Herein, a three-strain inoculum was used to
investigate the dynamics of systemic staphylococcal disease.
Female BALB/c mice were infected intravenously at 7–8 weeks
of age with a mixed inoculum of NewHG strains (GMSA021-023)
at a 1:1:1 ratio totaling 16107 CFU. At 30 minutes and then at 2,
6, 12, 24, 48 and 72 hours post infection, mice were sacrificed and
their visceral organs (kidneys, liver, spleen, heart and lungs) were
harvested for bacterial enumeration by homogenization, serial
dilution and plating on selective media (n = 8–10 mice per time-
point). Bacterial numbers in the blood were found to be
consistently low, approaching the limit of detection at all time-
points, and are therefore not included in the analysis. Pilot data
indicated that the bacteria were unlikely to be found at other sites
(including brain, thigh muscle/bones and the site of infection, i.e.
tail).
A large fraction of the bacterial inoculum was restricted to the
liver and spleen for several hours post infection. Neither extreme
clonality nor an overall increase in bacterial numbers were
observed at this stage, indicating that little bacterial growth was
occurring, or that there was an equilibrium between bacterial
growth and killing by the host (Figure 2). As the infection
progressed, bacteria were found transiently in the heart (peaking at
12 hours post infection) and then in increasingly large numbers in
the kidneys (peaking at 2–3 days post infection) (Figure 2A).
Bacteria in the kidneys showed a high degree of clonality, in most
cases representing only one or two strains out of three.
Occasionally, highly-clonal bacterial populations were found in
the liver at later time-points. This dramatic increase in clonality
over time is shown in Figure 2B. Data for individual organs at each
time-point are given in supplementary Figure S2. One mouse
(labelled ‘‘*’’ in Figure S2) was sacrificed for humane reasons due
to ill health at 42 hours post infection and was excluded from the
general analysis.
Sub-curative concentrations of tetracycline alter the
dynamics of a staphylococcal infection in zebrafish
Clonal expansion of bacteria has important implications during
mixed-strain infections, especially when a drug-resistant mutant is
present among a population of sensitive organisms, and the
zebrafish infection model allowed us to investigate this process.
The antibiotic dose required to produce a significant reduction in
mortality in the zebrafish embryo model can, in some cases,
approach fifty times the in vitro MIC. It was hypothesized that a
low antibiotic dose, i.e. one that produces no response in fish
infected with a drug-sensitive strain, might still offer a preferential
advantage to drug-resistant bacteria, as has been observed in vitro
[23].
In order to define an appropriate drug concentration, tetracy-
cline response experiments were conducted, whereupon embryos
infected with 1500 CFU SH1000 EryR (GMSA015) were
immersed in sterile E3 medium containing a range of antibiotic
doses for the duration of the experiment (Figure S3A).While
50 mg/ml tetracycline produced a highly significant, curative
response (p= 0.0003), 10 mg/ml tetracycline showed a trend
towards curing (p = 0.0753) and 5 mg/ml was entirely sub-curative
(p= 0.2181). We therefore chose 2.5 mg/ml tetracycline for
subsequent experiments. Embryos treated with sub-curative
2.5 mg/ml tetracycline contained approximately 106 CFU of
EryR bacteria upon death (Figure S3B), demonstrating no
reduction in terminal bacterial load at this dose. This control
indicates that any observed skewing of the population in favor of a
resistant strain at this antibiotic concentration would not result
from failure of the sensitive strain to grow to normal levels in vivo.
Lastly, bacterial growth kinetics were assayed in vivo using either
the EryR or TetR strain injected alone into zebrafish embryos and
either left untreated or treated with 2.5 mg/ml tetracycline.
Neither strain showed significantly different growth kinetics in vivo
in the presence of tetracycline (p.0.9) (Figure S4), indicating that
the skewing effect is not simply due to a change in growth rate
within the host organism. Growth rate controls were not
performed in vitro because the antibiotic concentrations involved
would not correspond well with in vivo work. Experiments
performed by others show that low antibiotic doses can indeed
select for resistant mutants in vitro over the long term [23], but that
the effect requires a far greater number of generations than
exhibited by bacterial growth in our in vivo experiments.
To ascertain whether a sub-curative dose of antibiotic was
indeed able to influence bacterial population dynamics, embryos
were infected with a total of 1500 CFU SH1000 EryR and TetR
(GMSA015 and GMSA017 mixed 1:1), and treated with sub-
curative 2.5 mg/ml tetracycline. Treated and untreated embryos
showed no difference in mortality (Figure 3A, p = 0.7412) or in
total bacterial numbers per embryo upon death (Figure 3B,
p= 0.1452). There were, however, significant differences in the
ratios between the strains isolated from treated and untreated
embryos (Figure 3C, p= 0.0143). Lowering the tetracycline dose to
1 mg/ml abolished this effect (Figure S3C, p= 0.1008), implying a
narrow window (approximately four-fold) in which the antibiotic
dose is low enough to be statistically sub-curing but high enough to
influence population dynamics. Bacteria recovered from these
experiments were invariably found to be resistant to a single
antibiotic alone, therefore the change in output ratio is not due to
the spontaneous generation of resistance among the sensitive
population (as bacteria that had acquired resistance to tetracycline
in this way would remain erythromycin-resistant). Phagocyte
depletion of infected zebrafish, which has been previously shown
to prevent stochastic population variation [5], resulted in
untreated and treated groups that were statistically similar even
after treatment with a higher dose of 10 mg/ml tetracycline
(Figure 3D; p= 0.4855), indicating that phagocytes play a role in
the antibiotic skewing phenomenon, and again supporting the
hypothesis that phagocytes are an important host niche during
S. aureus infection.
In vivo selection of resistant clones occurs among other
strains, genera and antibiotic classes
To discover whether the phenomenon is consistent among other
S. aureus strain backgrounds, the same experiments were conducted
using NewHG EryR and TetR (GMSA021 and GMSA023).
2.5 mg/ml tetracycline was again shown in pilot experiments to be
non-curative in fish infected with the sensitive strain alone (Figure
S5A, p= 0.5443). Results of the NewHG mixed population
experiment (1500 CFU, 1:1) were consistent with those obtained
for SH1000, showing similar embryo mortality between the
treated and untreated groups (Figure S5B, p= 0.4575), similar total
CFU recovered from both groups (Figure S5C, p= 0.4068) and a
statistically significant difference between the strain ratios
Staphylococcus aureus In Vivo Population Dynamics
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(Figure 4A, p = 0.0296). As expected, this was abolished in
phagocyte-depleted embryos at 10 mg/ml tetracycline (Figure
S5D, p= 0.2956). Therefore the preferential selection of antibiotic-
resistant bacteria at low levels of antibiotic is not limited to a single
S. aureus strain.
The Gram-negative pathogen Pseudomonas aeruginosa is common-
ly isolated alongside S. aureus in the lungs of patients with cystic
fibrosis [31] and is able to modulate S. aureus growth and virulence
factor expression during polymicrobial wound infection [35]. To
explore the possibility that extreme skewing of strain ratios extends
to genera of bacteria other than Staphylococcus, two drug-resistant
P. aeruginosa PAO1-L derivatives, gentamicin-resistant GmR
(GMPA001) and tetracycline-resistant TetR (GMPA002), were
constructed. As expected from previous work by others [36,37],
Figure 2. The bacterial strain distribution in mouse organs at various time-points post infection.Mice were infected with a 1:1:1 mixture
of three marked S. aureus NewHG strains (n = 8–10 mice per time-point). (A) The change in total CFU load over time in each organ (BD: below limit of
detection). (B) The number of organs at each time-point that show either single-strain dominance (one strain $1006 the other two), double-strain
dominance (two strains $1006 the third), spread dominance (highest and lowest strains differ by $1006, with the middle strain within 1006 of
both) or no dominance (all strains are within 1006 of one another).
doi:10.1371/journal.ppat.1003959.g002
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live PAO1 (but not heat-killed PAO1) is lethal to zebrafish
embryos when injected into the circulation, even at infectious
doses as low as 100 CFU (Figure S6A). P. aeruginosa has a naturally
high intrinsic resistance to tetracycline and was therefore
unaffected by all attempts to cure the infection (Figure S6B) using
drug doses that were not harmful to the embryo (#100 mg/ml). In
mixed population experiments with 50 mg/ml tetracycline
(200 CFU, 1:1), it was again observed that a lack of significant
effect on embryo mortality (Figure S6C, p = 0.9449) or terminal
CFU load (Figure S6D, p= 0.4474) did not prevent the selection
phenomenon from occurring (Figure 4B, p= 0.0169). It is
noteworthy, however, that P. aeruginosa does not reach a specific
bacterial load before embryo mortality (unlike S. aureus, which
consistently reaches approximately 106 CFU). Furthermore, in
contrast to the S. aureus strains tested above, phagocyte depletion of
the host does not abolish the selection phenomenon in P. aeruginosa
(Figure S6E, p,0.0001). Thus, despite the difference between S.
aureus and P. aeruginosa population kinetics (and therefore infection
dynamics) in vivo, the two species exhibit the same phenomenon
with regards to selection at sub-curative antibiotic doses.
It was hypothesized that the effect of sub-curative antibiotic
doses on strain ratios might not be restricted to tetracycline. To
test this, clinical MRSA isolate BH1CC and its methicillin-
sensitive, tetracycline-resistant isogenic partner [38] were used.
Experiments were carried out in an identical manner to
tetracycline (i.e. immersion of embryos in antibiotic). It was found
that 32 mg/ml oxacillin had no effect on the mortality of zebrafish
infected with 1500 CFU of either the sensitive strain alone (Figure
S7A, p= 0.5390) or a 1:1 mixture of sensitive and resistant strains
(Figure S7B, p= 0.2087). Although the total bacterial load upon
death was marginally but significantly decreased using this dose of
oxacillin (Figure S7C, p,0.0001), this may be explained by the
bactericidal action of oxacillin versus the bacteriostatic nature of
tetracycline used in previous experiments. Nonetheless, such a
decrease had no effect on the disease state or mortality of the
infected host. This sub-curative dose of oxacillin produced a highly
significant skew towards the resistant strain (Figure 4C,
p= 0.0003), indicating that the phenomenon is not restricted to
tetracycline and is likely to be an important factor in the clinical
treatment of mixed MRSA-MSSA infections. Curiously, the
skewing effect was also evident to a minor but significant degree
in phagocyte-depleted embryos (Figure S7D, p= 0.0018) treated
with the same oxacillin dose, suggesting both phagocyte dependent
and independent effects. Selection was not significant at 16 mg/ml
oxacillin, suggesting a 2-fold concentration range for the effect
(Figure S7E, p= 0.0964).
Interestingly, antibiotics have been proposed to share a
common killing mechanism involving accumulation of reactive
Figure 3. The effect of a sub-curative antibiotic dose on zebrafish embryos infected with S. aureus SH1000. Embryos were infected with
a 1:1 mixture of SH1000 EryR:TetR bacteria and treated with 2.5 mg/ml or 10 mg/ml tetracycline as indicated. (A) Zebrafish mortality curve (n = 60–65
per group). (B) Total terminal bacterial load per embryo. (C) Terminal EryR/TetR strain ratio per embryo. (D) Terminal EryR/TetR strain ratio per pu.1
morphant (phagocyte-depleted embryo). Solid lines indicate mean (B) and median (C, D) values.
doi:10.1371/journal.ppat.1003959.g003
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oxygen species (ROS) within bacterial cells, and subsequent death
from oxidative stress, irrespective of the antibiotic target or direct
mechanism of action [39]. However, recent reports have
questioned the role of ROS in the activity of bactericidal
antibiotics [40,41]. Therefore, the important components of
staphylococcal oxidative stress resistance AhpC and KatA [42]
were tested for their role in resistant clone selection in vivo (Figure
S7F). Since the virulence of the katA ahpC double mutant (strain
KC043) was not affected by oxacillin relative to its SH1000 parent
at all concentrations tested (p.0.74), it is unlikely that ROS play a
role in antibiotic skewing in the in vivo infection model.
Erythromycin is another medically relevant drug which our
strain constructs enabled us to test. In the zebrafish embryo model,
however, erythromycin proved unable to affect the outcome of
infection by immersion alone. Instead, the antibiotic dose was
introduced by microinjection not more than two hours after
bacterial infection (untreated controls were instead injected with
PBS). Results showed no significant difference between treated
and untreated groups when comparing mortality during a single-
strain infection (Figure S8A, EryR p = 0.0804, TetR p = 0.9964) or
during a mixed infection (Figure S8B, p= 0.2695), nor was there a
significant difference in terminal bacterial load (Figure S8C,
p = 0.4438). Yet, again, there was a significant difference in
terminal strain ratios (Figure 4D, p= 0.0022). Similarly to
tetracycline, no cross-resistance was observed in the strains
recovered from embryos post mortem. Therefore, preferential
selection of resistant strains (not associated with the spontaneous
generation of resistant mutants) results from treatment with sub-
curative doses of multiple antibiotic classes.
In vivo selection of resistant clones occurs in the
mammalian host
In order to extend our findings to mammalian infection,
antibiotic skewing experiments were performed using tetracycline
in the murine model. Briefly, mixed-strain infections were carried
out as for the population dynamics experiments above, and mice
were treated with low doses of tetracycline in their drinking water.
Mice were sacrificed two days post infection, when the majority of
bacteria were expected to be found in clonal abscesses within
organs (i.e. kidneys, liver and spleen), which were assayed for
bacterial load.
In preliminary experiments, the sub-curative tetracycline dose
varied between animal groups. Two doses (0.1 mg/ml and
0.2 mg/ml) were therefore used in the final experiment alongside
an untreated control (Figure 5). There was no significant difference
in total CFU per mouse for either dose compared to the control
(p= 0.1965 and p = 0.4194 respectively). Pooled data (i.e. the sum
total of bacteria of each strain per mouse) showed a trend towards
Figure 4. The effect of sub-curative antibiotic doses on zebrafish embryos infected with a variety of pathogens. Embryos were
infected with a 1:1 mixture of (A) S. aureus NewHG EryR:TetR bacteria (treated with 2.5 mg/ml tetracycline), (B) P. aeruginosa PAO1-L GmR:TetR
bacteria (treated with 50 mg/ml tetracycline), (C) S. aureus BH1CC OxS:OxR bacteria (treated with 32 mg/ml oxacillin) or (D) S. aureus SH1000 EryR:TetR
bacteria (treated with 100 mg/ml erythromycin). Terminal sensitive/resistant strain ratio per embryo is shown in each case. Solid lines indicate median
values.
doi:10.1371/journal.ppat.1003959.g004
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the resistant subpopulation. The variance in the untreated group
compared to treated groups makes comparison by Mann-Whitney
test highly misleading in this model without using hundreds of
animals per group (an amount that would be impossible for both
practical and ethical reasons); therefore, a binomial distribution was
used to analyze these data. The underlying assumption of this
conservative test is that in an untreated mouse, there is a 50% chance
of skewing towards either strain (which is indeed what we observed;
5/10 towards TetR; p= 0.246). The comparison showed that whilst
0.1 mg/ml did not give a significantly non-stochastic result (6/10
TetR, p= 0.205), 0.2 mg/ml did (8/9 TetR and one mouse not
skewed, p= 0.0176). Therefore a sub-curative antibiotic dose is able
to cause preferential selection of resistant microorganisms during
mammalian infection. Furthermore, as expected from our murine
infection kinetics experiment, selection at this low antibiotic
concentration was a result of growth in the kidneys (p= 0.0349)
rather than liver (p= 0.2188) or spleen (p= 0.2344) (Figure S9).
Discussion
Although Staphylococcus aureus is an important and increasingly
antibiotic-resistant human pathogen, little is known about its
disease progression or how antibiotic levels affect population
dynamics. This is particularly pertinent for the understanding of
S. aureus behavior in a hospital environment, in agriculture or
even in the community at large, given the failure of some patients
to complete prescribed antibiotic courses.
Construction of a set of isogenic strains that produce clonal
lesions in the host demonstrated stochastic strain variance during
zebrafish embryo infection. In the mouse it was shown that kidney
abscesses form in the later stages of infection and each likely
originates from a single bacterial founder. Interestingly, most of
the initial inoculum is localized to the liver and spleen during the
early stages of infection (up to approximately one day post
intravenous administration). It is unknown whether bacterial cells
founding renal abscesses were physically associated with the
kidneys during this critical period, or whether individual bacteria
‘‘seed’’ the kidneys after travelling from another organ such as the
liver, spleen, lungs, heart or blood at a later stage. Observation of a
mouse that showed a dramatic, systemic infection of just two
strains strongly implies that spread to secondary organs can occur
after an initial period of clonal expansion. The variable speed at
which growth occurs in the kidneys may be indicative of lesion
founders ‘‘seeding’’ the kidneys at different times, especially in the
case where two or more strains reach substantial but unequal
numbers, given that no strain has a competitive advantage in
terms of growth rate. In a peritoneal infection model, Rauch and
colleagues reported parenchymal kidney abscesses that were
identical to those observed post-intravenous infection, and that
peritoneum-associated kidney surface abscesses were not associat-
ed with parenchymal abscesses [43]. Despite their role in
controlling infection [44], host phagocytes may form the reservoir
or delivery vehicle for S. aureus infection [5–8].
Although S. aureus colonization is not directly correlated with
mortality [45], the presence of a mixed population of resistant and
sensitive bacteria in the host provides a convenient ‘‘head start’’
for resistant bacteria to outgrow the sensitive strain and reach
transmissible levels, should the patient become exposed to
antibiotics. In the absence of treatment, however, resistance to
antimicrobials has typically been thought to impose a fitness cost
that enables the parent strain to outcompete antibiotic-resistant
strains [18]. We have shown that this is not always the case, as
even in the absence of apparent selective pressure, clonal
expansion ensures that a pool of resistant bacteria can grow to
dominant levels.
The use of antibiotics is the primary driving force behind the
development of resistance [24]. It has been shown in S. aureus that
vancomycin treatment is able to greatly increase a pool of resistant
organisms inside a host [46] and that de novo resistance to
tetracycline can arise when the drug is given orally at high levels
[47]. Here, a combination of zebrafish embryo and murine
systemic infection models were used to examine the role of sub-
curative concentrations of antibiotics against multiple strains of S.
aureus and a Gram-negative pathogen, P. aeruginosa, in vivo. A level
of drug so low that it does not alter host mortality or bacterial load
(i.e. a dose that is sub-curative) is able to produce a statistically
significant skew in strain ratios towards a pre-existing resistant
subpopulation. In Escherichia coli, low levels of antibiotics such as b-
lactams promote stepwise mutations leading to resistance [22] and
in Pseudomonas aeruginosa, sub-lethal concentrations of several
antibiotics increase mutational frequency [30]. Sub-MIC doses
of antibiotics have been demonstrated not only to contribute to the
generation of resistant mutants, but also to allow a resistant
organism to outcompete its sensitive competitors in long-term in
vitro experiments [23].
Figure 5. The effect of sub-curative antibiotic doses on mice
infected with S. aureusNewHG.Mice were infected intravenously with
a 1:1 mixture of NewHG EryR:TetR bacteria and were treated by replacing
their drinking water with the indicated concentrations of tetracycline prior
to sacrifice two days later. (A) Total CFU per mouse at experimental
endpoint. (B) Total EryR/TetR strain ratio per mouse at experimental
endpoint. Solid lines indicate mean (A) and median (B) values.
doi:10.1371/journal.ppat.1003959.g005
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Critically, our result is not dependent upon development of
resistance in the sensitive subpopulation. Furthermore, selection of
resistant clones is not simply due to retardation of growth of the
sensitive bacteria caused by the antibiotic, as phagocyte-depleted
zebrafish embryos (wherein bacteria grow exponentially from the
outset of infection [48]) do not show a significant skew in favor of
the resistant strain, nor did in vivo growth kinetics experiments
reveal a significant difference. Since phagocyte-depleted embryos
succumb to even a small bacterial dose within 18 hours [48], the
restricted growth of the pathogen within the first 24 hours during
our experiments suggests that all bacterial cells are captured by
phagocytes immediately upon infection, therefore preferential
phagocytosis is unlikely to be a factor. Instead, it is likely that the
antibiotic confers an advantage to the resistant strain over the
sensitive strain that allows it to better colonize the pre-expansion
‘‘niche’’ or somehow exploit that ‘‘niche’’ more effectively. This
phenomenon may be limited to organisms whose mode of
pathogenicity relies upon the stochastic selection of clones during
infection, but is not restricted to a single species or class of
antibiotic. It may be that such organisms are sensitive to low-dose
treatment at a particular stage of their infectious cycle, in a niche-
dependent fashion. Since the role of reactive oxygen species (ROS)
in the action of antibiotics is currently under debate [39–41] and
could provide an explanation for the skewing phenomenon, we
examined the effect of ROS during treatment using an S. aureus
strain (ahpC katA) defective in oxidative stress resistance [42].
Despite extreme sensitivity to oxidative stress the ahpC katA strain
was no more susceptible to tetracycline in vivo than its isogenic
parent, suggesting that ROS may not play a major role in a
generalized antibiotic effect. It is well known that the bacterial
transcriptome/proteome can fluctuate when exposed to sub-
curative antibiotic doses [49–52], and this is an area of study that
can be pursued in future work.
Environmental concentrations of antibiotics are commonly
found in the ng/L to mg/L range except in extreme cases
[53,54], several orders of magnitude lower than the concentrations
tested in our in vivo work. We have focused, therefore, on medical
treatment of infection. The global spread of antibiotic resistance is
a serious threat to human health that must be acted on, as it is
inevitable that high-dose antimicrobial chemotherapy increases
the selective pressure on the target organism. This has led to an
argument that aggressive treatment regimes, such as those
currently prescribed, should be reconsidered and that alternative
patterns of treatment might be indicated [55]. As discussed above,
however, it is becoming accepted that lower drug doses promote
stepwise development of resistance and that aggressive drug use
dramatically reduces the potential pool of clones from which
resistance can develop. Given this information and our data
showing that sub-curative antibiotic doses are still able to select for
pre-existing resistant organisms, we suggest that removal of the
sensitive bacteria before they can develop resistance is still the best
strategy for control of microbial disease. Although we have not
determined the concentrations of antibiotics active in host tissues,
we note that the elimination half-lives of the antibiotics tested in
this study vary considerably, from 30 minutes (oxacillin) to 6–
12 hours (tetracycline) [56]. Coupled with our evidence that the
sub-curative but selective dose range is two- to four-fold, we
hypothesize that bacteria are likely to be in contact with a relevant
drug concentration for ample time for selection to occur during
treatment. Furthermore, many antibiotics including oxacillin and
tetracycline share a renal route of elimination [56], which concurs
with our murine experiments suggesting that the kidneys are
important for the antibiotic effects discussed. The exposure time
would be greatly amplified by ‘‘pulsed’’ antibiotic therapy. The
effect of sub-curative antibiotics may seem modest, however, we
note that the evolution of any organism does indeed occur as a
result of modest competitive advantages. We believe that our
results are indicative of a growing trend in the response of bacterial
pathogens to antibiotics, and conclude that carefully prescribed,
high-dose antimicrobial chemotherapy remains preferable over
the alternatives at this time.
Materials and Methods
Ethics statement
Animal work (both mice and zebrafish) was carried out according
to guidelines and legislation set out in UK law in the Animals
(Scientific Procedures) Act 1986, under Project Licenses PPL 40/
3123, PPL 40/3699 and PPL 40/3574. Ethical approval was
granted by the University of Sheffield Local Ethical Review Panel.
Bacterial strains and growth conditions
Staphylococcus aureus strains (Table S1) were grown using brain
heart infusion (BHI) liquid or solid medium (Oxoid) at 37uC,
supplemented with the following antibiotics where appropriate:
kanamycin 50 mg/ml, tetracycline 5 mg/ml or erythromycin 5 mg/
ml plus lincomycin 25 mg/ml (Sigma-Aldrich). Pseudomonas aerugi-
nosa strains (Table S1) were grown using Luria-Bertani (LB) liquid
or solid medium (Oxoid) at 37uC, supplemented with the following
antibiotics where appropriate: tetracycline 125 mg/ml or genta-
micin 20 mg/ml (Sigma-Aldrich).
Construction of antibiotic-resistant S. aureus strains
The suicide vector pMUTIN4 [57] was used to integrate
various antibiotic resistance cassettes downstream of the lysA gene
(which encodes the terminal enzyme in the lysine biosynthetic
pathway) in S. aureus. This provided a convenient method of
screening to ensure that clones retained a wild type phenotype;
undesired disruptions of lysA would result in lysine auxotrophy.
Growth of clones in chemically defined minimal medium lacking
lysine showed that the wild type lysA gene remained intact. After
construction by standard PCR and restriction/ligation methods,
plasmids were introduced into S. aureus RN4220 by electropora-
tion, whereupon they integrated into the chromosome via
homologous recombination. The resulting resistance markers were
then transferred into other S. aureus strains as required by W11
transduction. pMUTIN4 provided erythromycin/lincomycin re-
sistance (EryR), whereas pAISH1 [58] was used to integrate
tetracycline resistance (TetR) and pGM072 (pMUTIN4 in which
erythromycin resistance was replaced by the resistance cassette
from pGL433 [59]) was used to integrate kanamycin resistance
(KanR). BH1CC and its derivative [38] were kindly provided by
James O’Gara (University College Dublin).
Construction of antibiotic-resistant P. aeruginosa strains
P. aeruginosa PAO1-L derivatives were constructed by integration
of mini-Tn7 to a neutral locus according to published protocols
[60]. Plasmids containing mini-Tn7 marked with either a
gentamicin or tetracycline resistance cassette (GmR or TetR
respectively) were kindly provided, along with invaluable assis-
tance, from Stephan Heeb (University of Nottingham).
Zebrafish maintenance and microinjection
London wild-type (LWT) zebrafish embryos (bred in the MRC
CDBG aquarium facilities at the University of Sheffield; see Ethics
Statement) were used for all experiments and were incubated in
E3 medium at 28uC according to standard protocols [61]. In order
to obtain phagocyte-depleted embryos, morpholino-modified
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antisense oligomers against pu.1 [62] were injected using a method
described previously [48]. Anaesthetized embryos at 30 hours post
fertilization were embedded in 3% w/v methylcellulose and injected
individually using microcapillary pipettes filled with bacterial
suspension of known concentration into the circulation, as
previously described [48]. Following infection, embryos were kept
individually in 100 ml E3 medium (with or without experimental
antibiotics), observed frequently up to 92 hours post infection, dead
embryos removed and numbers recorded at each time point.
Intravenous mouse injections
Female BALB/c mice were purchased from Harlan (UK) and
maintained at the University of Sheffield using standard
husbandry procedures. The 7–8 week old mice were inoculated
in the tail vein with 100 ml of S. aureus suspension in endotoxin-free
PBS (Sigma) corresponding to 16107 CFU per mouse. Viable
bacteria in the inoculum were plated on BHI (plus appropriate
antibiotics) after serial decimal dilution to confirm the accuracy of
the bacterial dose. Mice were monitored and sacrificed at various
time-points according to experimental design.
Determination of in vivo bacterial load
In order to recover bacteria from host tissues, whole zebrafish
embryos or mouse organs were individually homogenized in a
suitable volume of PBS using the PreCellys 24-Dual (Peqlab).
Homogenates were serially diluted in PBS and plated on BHI (S.
aureus) or LB (P. aeruginosa) agar supplemented with appropriate
antibiotics to determine bacterial numbers.
Statistical analysis
Survival experiments were evaluated using the Kaplan-Meier
method. Comparisons between curves were performed using the log
rank test. For comparisons between two CFU groups, a two-tailed,
unpaired Student’s t-test was used. For comparisons of strain ratios
between two groups (e.g. treated and non-treated) in zebrafish
embryos, a (non-parametric) Mann-Whitney U test was used.
Analysis was performed using Prism version 6.0 (GraphPad) and
statistical significance was assumed at p,0.05. In addition, analyses
via generalized linear models, linear models on transformed data
and Kruskall Wallace tests were performed and provided the same
insights. Strain ratios in mice were analyzed by binomial
distribution, as explained in Results. Figures show significance to
1 s.f. (p,0.05) or NS (p$0.05), and indicate either mean (CFU
comparison) or median (ratio comparison) values as appropriate.
Supporting Information
Figure S1 Comparison of fitness of antibiotic resis-
tance-tagged SH1000 strains. (A) Growth in aerated BHI
medium at 37uC. (B) Mortality of zebrafish embryos infected with
each strain (n = 20–25 per group).
(TIF)
Figure S2 The pattern of clonality observed during a
systemic murine infection. Pie charts show the distribution of
three strains in each organ, for each mouse at each time point.
Numbers inside rings indicate log10(CFU) in each organ (i.e. the
total bacterial load). Where total load was ,100 CFU, strain
distribution is not given, as presenting data this close to the
detection limit would be non-representative of true strain
dominance. The mouse marked * was culled 6 hours earlier than
the other mice in that group due to ill health and was not included
in general analyses throughout the paper.
(TIF)
Figure S3 The effect of tetracycline on zebrafish
embryos infected with S. aureus SH1000 strains. (A)
Mortality of zebrafish infected with SH1000 EryR alone and
treated with a range of tetracycline doses (n = 25–30 per group).
(B) Terminal EryR bacterial load per EryR-infected embryo,
treated with 2.5 mg/ml tetracycline. (C) Terminal EryR/TetR
strain ratio per embryo infected with a 1:1 mixture of SH1000
EryR:TetR bacteria and treated with 1 mg/ml tetracycline. Solid
lines indicate median values.
(TIF)
Figure S4 The effect of tetracycline on growth of S.
aureus SH1000 in vivo. Graphs show growth kinetics of (A)
EryR and (B) TetR. Zebrafish embryos were either left untreated
(circles) or treated with 2.5 mg/ml tetracycline (squares). Bacterial
CFU loads in living fish (n = 5 per group per time-point) at 1 and
7 hours post infection and every 12 hours thereafter, were
determined (white). Bacterial loads in any dead fish at each
time-point were also determined (black).
(TIF)
Figure S5 The effect of tetracycline on zebrafish
embryos infected with S. aureus NewHG strains. (A)
Mortality of zebrafish infected with NewHG EryR alone,
treated with a range of tetracycline doses (n = 30–35 per group).
(B) Mortality of zebrafish infected with a 1:1 mixture of NewHG
EryR:TetR, treated with 2.5 mg/ml tetracycline (n = 70–75 per
group). (C) Total terminal CFU load per embryo infected with a
1:1 mixture of NewHG EryR:TetR, treated with 2.5 mg/ml
tetracycline. (D) Terminal EryR/TetR strain ratio per pu.1
morphant (phagocyte-depleted embryo), treated with 10 mg/ml
tetracycline. Solid lines indicate mean (C) and median (D)
values.
(TIF)
Figure S6 The effect of tetracycline on zebrafish
embryos infected with P. aeruginosa PAO1 strains. (A)
Mortality of zebrafish inoculated with either live bacteria, heat-
killed bacteria or sterile PBS (n = 30–35 per group). (B) Mortality
of zebrafish infected with PAO1 GmR alone, treated with a range
of tetracycline doses (n = 55–60 per group). (C) Mortality of
zebrafish infected with a 1:1 mixture of PAO1 GmR:TetR, treated
with 50 mg/ml tetracycline (n = 65–70 per group). (D) Total
terminal CFU load per embryo infected with a 1:1 mixture of
PAO1-L GmR:TetR, treated with 50 mg/ml tetracycline. (E)
Terminal GmR/TetR strain ratio per pu.1 morphant (phagocyte-
depleted embryo), treated with 50 mg/ml tetracycline. Solid lines
indicate mean (D) and median (E) values.
(TIF)
Figure S7 The effect of oxacillin on zebrafish embryos
infected with S. aureus strains. (A) Mortality of zebrafish
infected with BH1CC DmecA::tetR (OxS) alone, treated with a
range of oxacillin doses (n = 40–60 per treated group, n = 80
untreated). (B) Mortality of zebrafish infected with a 1:1 mixture of
BH1CC OxS:OxR, treated with 32 mg/ml oxacillin (n = 65–70
per group). (C) Total terminal CFU load per embryo infected with
a 1:1 mixture of BH1CC OxS:OxR, treated with 32 mg/ml
oxacillin. (D) Terminal BH1CC OxS/OxR strain ratio per pu.1
morphant (phagocyte-depleted embryo), treated with 32 mg/ml
oxacillin. (E) Terminal BH1CC OxS:OxR strain ratio in zebrafish
treated with 16 mg/ml oxacillin. (F) Mortality of zebrafish infected
with either SH1000 or KC043 (katA ahpC), treated with a range of
oxacillin doses (n = 20–22 per group). Solid lines indicate mean (C)
and median (D, E) values.
(TIF)
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Figure S8 The effect of 100 mg/ml (sub-curing) erythro-
mycin on zebrafish embryos infected with S. aureus
SH1000 strains. (A) Mortality of zebrafish infected with either
SH1000 EryR or TetR individually (n = 80–90 per group). (B)
Mortality of zebrafish infected with a 1:1 mixture of SH1000
EryR:TetR (n = 80 per group). (C) Total terminal CFU load per
embryo infected with a 1:1 mixture of SH1000 EryR:TetR. Solid
lines indicate mean values.
(TIF)
Figure S9 The effect of sub-curative antibiotic doses on
the pattern of S. aureus NewHG infection in different
murine organs. EryR/TetR strain ratio is given for (A) kidneys,
(B) livers and (C) spleens at two days post infection. Only organs
that contained bacterial CFU above the limit of detection are
shown. Solid lines indicate median values.
(TIF)
Table S1 Bacterial strains and plasmids used in this
study.
(DOCX)
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